C88.00
Waldenström macroglobulinemia not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Lymphoplasmacytic lymphoma with IgM-production, NOS
- Lymphoplasmacytic lymphoma with IgM-production not having achieved remission
- Lymphoplasmacytic lymphoma with IgM-production with failed remission
- Macroglobulinemia (idiopathic) (primary) NOS
- Macroglobulinemia (idiopathic) (primary) not having achieved remission
- Macroglobulinemia (idiopathic) (primary) with failed remission
- Waldenström macroglobulinemia NOS
- Waldenström macroglobulinemia with failed remission
Medical Intelligence & Overview
Waldenström macroglobulinemia is a rare type of blood cancer that affects the lymphatic system, specifically involving the abnormal growth of lymphoplasmacytic cells that produce immunoglobulin M (IgM). When this illness has not responded to treatment or has relapsed, it is classified as 'not having achieved remission.' This condition is often referred to as primary macroglobulinemia or lymphoplasmacytic lymphoma with IgM production and is categorized under ICD-10 code C88.00. Recognizing the characteristics of this disease is essential for understanding its implications and management options.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphoid cells Family history of blood cancers or lymphoproliferative disorders Certain infections that may impact the immune system Environmental exposures such as chemicals or radiation
Key Symptoms: Weakness and fatigue Unexplained weight loss Swollen lymph nodes Night sweats Fever Bleeding or easy bruising Vision problems due to increased blood viscosity Headaches or dizziness Numbness or tingling in hands or feet
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Waldenström macroglobulinemia involves a combination of blood tests, bone marrow examination, and imaging studies. Key diagnostic indicators include elevated levels of IgM antibodies in the blood, abnormal lymphoplasmacytic cells in the bone marrow, and clinical symptoms such as enlarged lymph nodes or spleen. Additional testing such as flow cytometry, genetic analysis, and protein electrophoresis often assist in confirming the diagnosis and evaluating disease progression.
Treatment Protocols: Chemotherapy to reduce abnormal cell growth Targeted therapies aimed at specific molecules involved in cancer progression Plasmapheresis to decrease blood viscosity caused by high IgM levels Immunotherapy to boost the body's immune response Supportive care including transfusions and antibiotics for infections
Clinical Advice & FAQs
Billing Guidance
Is C88.00 a billable ICD-10 code?
Yes, C88.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C88.00?
Clinical documentation must specify the nature of Waldenström macroglobulinemia not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference